---
title: "12 Health Care Stocks Moving In Monday's Intraday Session"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/298949383.md"
description: "During Monday's intraday session, several healthcare stocks experienced significant volatility. Gainers included Basel Medical Group (up 59.8%), Scinai Immunotherapeutics (up 45.18%), and AIxCrypto Hldgs (up 30.45%). Conversely, major losers featured Q/C Technologies, which plummeted 66.1%, followed by Cellectis (down 40.49%) and Connect Biopharma Hldgs (down 18.39%). The report highlights these specific price movements and market capitalizations for the listed entities."
datetime: "2026-09-14T17:06:10.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/298949383.md)
  - [en](https://longbridge.com/en/news/298949383.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/298949383.md)
generator: "portal-rs"
---

# 12 Health Care Stocks Moving In Monday's Intraday Session

### Gainers

-   **Basel Medical Group** (NASDAQ:BMGL) shares moved upwards by 59.8% to $7.32 during Monday's regular session.
-   **Scinai Immunotherapeutics** (NASDAQ:SCNI) stock increased by 45.18% to $2.41. The company's market cap stands at $1.1 million.
-   **AIxCrypto Hldgs** (NASDAQ:AIXC) stock increased by 30.45% to $1.17. The company's market cap stands at $18.9 million.
-   **EUDA Health Holdings** (NASDAQ:EUDA) shares increased by 28.47% to $17.28. The company's market cap stands at $40.2 million.
-   **GT Biopharma** (NASDAQ:GTBP) shares increased by 18.46% to $10.2. The market value of their outstanding shares is at $15.5 million.
-   **Picard Medical** (AMEX:PMI) shares increased by 15.57% to $6.16. The company's market cap stands at $10.9 million.

### Losers

-   **Q/C Technologies** (NASDAQ:QCLS) stock fell 66.1% to $0.58 during Monday's regular session. The company's market cap stands at $14.0 million.
-   **Cellectis** (NASDAQ:CLLS) stock declined by 40.49% to $1.84. The market value of their outstanding shares is at $312.2 million.
-   **Connect Biopharma Hldgs** (NASDAQ:CNTB) shares decreased by 18.39% to $1.67. The company's market cap stands at $128.4 million.
-   **Lexaria Bioscience** (NASDAQ:LEXX) shares declined by 16.38% to $3.32. The market value of their outstanding shares is at $8.3 million.
-   **Onconetix** (NASDAQ:ONCO) shares fell 14.84% to $0.64. The company's market cap stands at $3.3 million.
-   **AEON Biopharma** (AMEX:AEON) stock decreased by 14.3% to $0.28. The market value of their outstanding shares is at $16.3 million. **See Also:** www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

### Related Stocks

- [BMGL.US](https://longbridge.com/en/quote/BMGL.US.md)
- [CNTB.US](https://longbridge.com/en/quote/CNTB.US.md)
- [SCNI.US](https://longbridge.com/en/quote/SCNI.US.md)
- [CLLS.US](https://longbridge.com/en/quote/CLLS.US.md)
- [AIXC.US](https://longbridge.com/en/quote/AIXC.US.md)
- [EUDA.US](https://longbridge.com/en/quote/EUDA.US.md)
- [GTBP.US](https://longbridge.com/en/quote/GTBP.US.md)
- [PMI.US](https://longbridge.com/en/quote/PMI.US.md)
- [QCLS.US](https://longbridge.com/en/quote/QCLS.US.md)
- [LEXX.US](https://longbridge.com/en/quote/LEXX.US.md)
- [ONCO.US](https://longbridge.com/en/quote/ONCO.US.md)
- [AEON.US](https://longbridge.com/en/quote/AEON.US.md)
- [EUDAW.US](https://longbridge.com/en/quote/EUDAW.US.md)
- [LEXXW.US](https://longbridge.com/en/quote/LEXXW.US.md)

## Related News & Research

- [Basel Medical Group Issues 6,000,000 Shares Following Cashless Warrant Exercises](https://longbridge.com/en/news/303545824.md)
- [Cellectis plans Phase 1 trial of .HEAL-101 in China, expects initial data in second half of 2027](https://longbridge.com/en/news/303371645.md)
- [Cellectis SA - Depositary receipt price target decreased by 12.50% to $3.18](https://longbridge.com/en/news/302906803.md)
- [Scinai Immunotherapeutics Ltd. (SCNI) Secures $5.1M CDMO Work, Runway to Late 2027](https://longbridge.com/en/news/302424934.md)
- [Scinai Immunotherapeutics Secures $4 Million via Private Placement and Warrant Inducement](https://longbridge.com/en/news/301996939.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**